Loading provider…
Loading provider…
Neurology Physician in Bakersfield, CA
NPI: 1285825455Primary Practice Location
Jeri Yvonne Movement Disorders Neurology Inc.
8327 Brimhall Rd, Bakersfield, CA
Primary Employer
Jeri Yvonne Movement Disorders Neurology Inc.
drjeriyvonneneurology.com
HQ Phone
Get M.D. Jeri's Phone NumberMobile
Get M.D. Jeri's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
MT State Medical License
2025 - 2027
CA State Medical License
2012 - 2026
OR State Medical License
2025 - 2025
AL State Medical License
2011 - 2013

American Board of Psychiatry and Neurology
Neurology
University of Alabama Medical Center
Fellowship • Neuromuscular Medicine (Neurology)
2011 - 2013
Rutgers Health/Robert Wood Johnson Medical School
Residency • Neurology
2008 - 2011
Center for Family Medicine
Internship • Transitional Year
2007 - 2008
American University of the Caribbean School of Medicine
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 259 | 441 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 112 | 172 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 56 | 56 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 21 | 21 |
Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease
Authors: Neil A. Kelly, Matthew P. Ford, David G. Standaert, Ray L. Watts, C. Scott Bickel
External quality assurance of tricyclic antidepressant measurements in serum: eight years of progress?
Authors: Wilson JF, Tsanaclis LM, Williams J, Tedstone JE, Richens A
Publication Date: 1989-01
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg